Hair Loss: Onion juice showed 87% regrowth in one study

The single trial behind viral hair loss claims

Social media posts promise dramatic hair regrowth from kitchen remedies. “Onion juice triggered full hair regrowth in 87% of patients,” wellness influencers claim. TikTok videos show twice-daily scalp applications. Beauty blogs call onion juice “nature’s hair loss cure.”

These claims originate from a 2002 clinical trial. Iraqi dermatologists tested crude onion juice on patients with alopecia areata, a chronic autoimmune disorder in which the immune system attacks hair follicles, causing patchy hair loss. The condition affects about 2% of the global population. The study reported that 86.9% of patients achieved full regrowth.

23 years later, onion juice appears in no major dermatology treatment guidelines. The 2023 comprehensive alopecia areata review excludes it from recommended therapies. The 2025 Brazilian Society of Dermatology consensus also omits any mention. No pharmaceutical companies have developed onion-based treatments. The single trial remains unreplicated.

Investigation of the original research explains why: dramatic laboratory findings rarely translate into widespread clinical adoption.

Dramatic regrowth in 87% of completers – but half the patients dropped out

The 2002 Baghdad Teaching Hospital study enrolled 62 patients with patchy alopecia areata. Study authors Khalifa Sharquie and Hala Al-Obaidi divided participants into treatment and control groups.

The preparation protocol was straightforward. Researchers used “Australian brown onions with high volatility,” according to the published methodology. They chopped the onions, extracted the juice using an electric blender, and stored it refrigerated. No concentration standardisation, chemical analysis, or stability testing was performed.

Both groups applied treatments twice daily for 2 months. The control group used tap water.

Hair regrowth began rapidly. “Hair regrowth started after just two weeks of treatment,” the authors reported. By 6 weeks, 20 of the 23 patients who completed treatment showed full regrowth. This represented 86.9% efficacy.

The authors compared their findings favourably with established treatments. “Onion juice had therapeutic effect comparable to BCG immunotherapy at 69% and topical immunotherapy at 58%,” they wrote. BCG—Bacillus Calmette-Guérin—uses bacteria to trigger immune responses.

However, the mechanism remained unclear. “The mechanism of action of crude onion juice in the treatment of alopecia areata is difficult to explain,” Sharquie and Al-Obaidi acknowledged.

They proposed two possibilities. First, antigenic competition—a mechanism in which an irritant substance causes inflammation that distracts the immune system from attacking hair follicles, potentially allowing regrowth. Second, direct irritant contact dermatitis from the sulphur and phenolic compounds in onion.

The irritant effect was observable. Fourteen of the 23 patients who completed treatment—60.8%—developed mild skin reddening during treatment.

The 49% dropout rate that calls results into question

The completion data indicate significant complications. The original onion juice group included 45 patients. During follow-up, 22 patients dropped out for unknown reasons, representing a 48.9% dropout rate. The control group began with 17 patients, with only 2 dropping out—an 11.8% dropout rate. This fourfold difference suggests severe selection bias. Patients who found onion juice intolerable, ineffective, or inconvenient likely left the study early. The reported 86.9% success rate therefore reflects only self-selected completers, not the broader patient population who began the trial.

“Some patients disliked the unpleasant odour of the treatment,” the authors noted. The distinctive smell created practical challenges. It also made true blinding impossible.

The 2019 systematic review by Hosking assigned the study a quality rating of two out of five. Reviewers categorised it as a “well-designed controlled trial without randomisation.” The review authors explained that this rating reflects significant methodological limitations, including the lack of random assignment to treatment groups. The high dropout rate raises additional concerns about the reliability of the results.

The study used tap water as the control treatment, which is a questionable placebo choice. The unmistakable onion odour made it obvious to participants which group they were in. This failure of blinding potentially introduced expectation bias, where believing a treatment works influences perceived results.

Twenty-three years later, still no replication or clinical adoption

No large-scale replication has been conducted 23 years after the original publication. Several factors account for this gap.

There are no commercial incentives. Crude onion juice cannot be patented, so companies have no financial motivation to fund rigorous trials. The distinctive odour prevents proper blinding in clinical studies. Lack of standardisation makes consistent dosing impossible. The messy application process discourages patient compliance over extended periods.

The study’s scope was limited to one specific condition. Alopecia areata is an autoimmune disorder, distinct from other types of hair loss. The findings do not apply to androgenetic alopecia—male and female pattern baldness—which affects far more people.

Onion juice remains an intriguing but unproven alternative treatment. The single methodologically limited study still awaits replication with larger samples, proper blinding, standardised preparations, objective outcome measures, and, critically, adequate participant retention to avoid selection bias that may have inflated the original success rate.